Research Paper Volume 15, Issue 19 pp 10253—10271
Development of a prognostic model based on anoikis-related genes for predicting clinical prognosis and immunotherapy of hepatocellular carcinoma
Figure 5. Independent cohort validation of the risk model developed based on the prognostic ARG. (A, B) Clinical prognostic analysis of HCC samples from the training and validation sets in the TCGA cohort. (C) Clinical prognostic analysis of HCC samples from the GSE76427 dataset. (D–F) Time-related ROC curve analysis of the TCGA cohort and the GSE76427 cohort at 1-, 3-, and 5-year.